TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
6,348
|
4,953
|
21,253 |
| Financial expenses |
44
|
24
|
25 |
| Earnings before taxes |
-278
|
-1,325
|
3,795 |
| EBITDA |
-225
|
-1,238
|
3,884 |
| Total assets |
6,562
|
7,677
|
9,501 |
| Current assets |
4,897
|
5,879
|
9,174 |
| Current liabilities |
504
|
1,093
|
1,598 |
| Equity capital |
5,879
|
6,367
|
7,465 |
| - share capital |
325
|
336
|
334 |
| Employees (average) |
5
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.6%
|
82.9%
|
78.6% |
| Turnover per employee |
1,270
|
991
|
4,251 |
| Profit as a percentage of turnover |
-4.4%
|
-26.8%
|
17.9% |
| Return on assets (ROA) |
-3.6%
|
-16.9%
|
40.2% |
| Current ratio |
971.6%
|
537.9%
|
574.1% |
| Return on equity (ROE) |
-4.7%
|
-20.8%
|
50.8% |
| Change turnover |
1,559
|
-16,410
|
11,783 |
| Change turnover % |
33%
|
-77%
|
124% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.